Given that certain class 1A tumors still progress to metastatic disease and that PRAME+ appears to be associated with increased metastatic disease rates, a positive PRAME expression status in a GEP class 1 tumor may explain the rare cases in this group that do metastasize. The gene discussed is PRAME; the disease is metastatic neoplasm.